Iterum Therapeutics plc (ITRMF) Shares Issued (2017 - 2025)

Iterum Therapeutics' Shares Issued history runs 9 years deep, the most recent figure standing at $940664.0 for Q3 2025.

• In Q3 2025, Shares Issued rose 82.6% year-over-year to $940664.0; the TTM figure through Sep 2025 stood at $940664.0 (up 82.6% YoY), while the FY2024 annual figure was $841720.0, down 24.1% from the prior year.
• Shares Issued for Q3 2025 stood at $940664.0, up from $760906.0 in the prior quarter.
• The five-year high for Shares Issued was $18.3 million in Q2 2022, with the low at $28176.0 in Q3 2022.
• The 5-year median for Shares Issued is $834227.0 (2025), against an average of $2.3 million.
• The sharpest annual moves came in 2022 and 2023: Shares Issued slumped 99.8% in 2022, then surged 3838.3% in 2023.
• Iterum Therapeutics' Shares Issued stood at $1.1 million in 2021, then plunged by 66.72% to $355591.0 in 2022, then surged by 211.87% to $1.1 million in 2023, then declined by 24.1% to $841720.0 in 2024, then grew by 11.75% to $940664.0 in 2025.
• Business Quant data shows ITRMF's Shares Issued at $940664.0 in Q3 2025, $760906.0 in Q2 2025, and $834227.0 in Q1 2025.